{"nct_id":"NCT06075537","title":"An Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp Alfa (DNL310) in Participants With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007","status":"ENROLLING_BY_INVITATION","status_verified_date":"2025-09","start_date":"2023-09-20","start_date_type":"ACTUAL","primary_completion_date":"2027-06","primary_completion_date_type":"ESTIMATED","completion_date":"2027-06","completion_date_type":"ESTIMATED","phases":["PHASE2","PHASE3"],"tickers":["DNLI"]}